1041-18: Barriers to the Implementation of Pharmacogenomics in Psychiatric Clinical Practice: An Integrative Review

Pharmacogenomics is the most selective and efficacious treatment approach for psychiatric disorders. The era of adverse drug reactions, treatment non-compliance, and stigmatization of the mentally ill because of the visible and irreversible side effects of psychotropic medication could eventually fade as PGx adoption accelerates in clinical practice.

Presenter:  David Nana Ampong, MSN, RN

Disclosures:  The presenter and planners have no conflict of interest or commercial support to disclose.  Off-label uses will not be discussed during this presentation.

Session Length:  1 Hour 4 minutes

Target Audience:  RN, APRN

Learning Outcome:
Upon completion of this presentation, the participant will be able to:

• Explain the history of PGx and where we are with its implementation. 

Keywords:  Pharmacogenomics, Pharmacokinetics, Pharmacodynamics

Continuing Nursing Education:
1.0 pharmacology contact hours.  * In order to receive contact hours, you must: Listen to presentation, complete an evaluation, and earn a passing score on the post-test before the expiration date. You will have 5 tries to correctly answer the questions on the post-test and a score of 80% is required to pass. Once you have passed and completed an evaluation, the certificate will be generated online, available for you to print immediately. You cannot earn credit unless all steps are completed.

The American Psychiatric Nurses Association is accredited with distinction as a provider of continuing nursing education by the American Nurses Credentialing Center's Commission on Accreditation.

Originally Presented
APNA 32nd Annual Conference
Columbus, Ohio
Wednesday, October 24, 2018
4:15pm - 6:15pm

The contact hours for this session expire:  December 31, 2020